Becaplermin for wound healing.
D000925:Anticoagulants / Q000627:therapeutic use; D054598:Blue Cross Blue Shield Insurance Plans; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy*; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration; D014945:Wound Healing
D000925:Anticoagulants; D010982:Platelet-Derived Growth Factor